A global phase 3, multicenter, randomized, trial, to Determine the Efficacy and Safety of Durvalumab in combination with Tremelimumab and Enfortumab Vedotin or Durvalumab in combination with Enfortumab vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or who refuse Cisplantin Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer. The goal of the study is to explore the triplet combination of Durvalumab, Tremelimumab and Enfortumab Vedotin in terms of efficacy and safety compared to the current Standard Of Care (SOC).
Service
The endocrine system is made of nerves and gland cells that make and send hormones throughout the body. Neuroendocrine and endocrine neoplasia occurs when those cells grow out of control and can lead to rare conditions, including the full range of hypothalamic, pituitary, adrenal and islet cell tumors. ...